Yield10 Bioscience, Inc. (YTEN) Misses Q2 EPS by 3c

Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q2 EPS of ($0.64), $0.03 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13